Biotechnology Portfolio Biotechnology Fund Market Value
| FBIOX Fund | USD 19.63 0.36 1.87% |
| Symbol | Biotechnology |
Biotechnology Portfolio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biotechnology Portfolio's mutual fund what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biotechnology Portfolio.
| 01/30/2025 |
| 03/01/2025 |
If you would invest 0.00 in Biotechnology Portfolio on January 30, 2025 and sell it all today you would earn a total of 0.00 from holding Biotechnology Portfolio Biotechnology or generate 0.0% return on investment in Biotechnology Portfolio over 30 days. Biotechnology Portfolio is related to or competes with Health Care, Technology Portfolio, Fidelity Select, Software And, and It Services. The fund invests primarily in common stocks More
Biotechnology Portfolio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biotechnology Portfolio's mutual fund current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biotechnology Portfolio Biotechnology upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0047 | |||
| Maximum Drawdown | 6.44 | |||
| Value At Risk | (1.99) | |||
| Potential Upside | 1.94 |
Biotechnology Portfolio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biotechnology Portfolio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biotechnology Portfolio's standard deviation. In reality, there are many statistical measures that can use Biotechnology Portfolio historical prices to predict the future Biotechnology Portfolio's volatility.| Risk Adjusted Performance | 5.0E-4 | |||
| Jensen Alpha | (0) | |||
| Total Risk Alpha | 0.0239 | |||
| Treynor Ratio | (0.03) |
Biotechnology Portfolio Backtested Returns
Biotechnology Portfolio secures Sharpe Ratio (or Efficiency) of -0.0551, which signifies that the fund had a -0.0551 % return per unit of risk over the last 3 months. Biotechnology Portfolio Biotechnology exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biotechnology Portfolio's Risk Adjusted Performance of 5.0E-4, standard deviation of 1.31, and Mean Deviation of 1.02 to double-check the risk estimate we provide. The fund shows a Beta (market volatility) of 0.62, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Biotechnology Portfolio's returns are expected to increase less than the market. However, during the bear market, the loss of holding Biotechnology Portfolio is expected to be smaller as well.
Auto-correlation | 0.76 |
Good predictability
Biotechnology Portfolio Biotechnology has good predictability. Overlapping area represents the amount of predictability between Biotechnology Portfolio time series from 30th of January 2025 to 14th of February 2025 and 14th of February 2025 to 1st of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biotechnology Portfolio price movement. The serial correlation of 0.76 indicates that around 76.0% of current Biotechnology Portfolio price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.76 | |
| Spearman Rank Test | -0.52 | |
| Residual Average | 0.0 | |
| Price Variance | 0.08 |
Biotechnology Portfolio lagged returns against current returns
Autocorrelation, which is Biotechnology Portfolio mutual fund's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Biotechnology Portfolio's mutual fund expected returns. We can calculate the autocorrelation of Biotechnology Portfolio returns to help us make a trade decision. For example, suppose you find that Biotechnology Portfolio has exhibited high autocorrelation historically, and you observe that the mutual fund is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Biotechnology Portfolio regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Biotechnology Portfolio mutual fund is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Biotechnology Portfolio mutual fund is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Biotechnology Portfolio mutual fund over time.
Current vs Lagged Prices |
| Timeline |
Biotechnology Portfolio Lagged Returns
When evaluating Biotechnology Portfolio's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Biotechnology Portfolio mutual fund have on its future price. Biotechnology Portfolio autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Biotechnology Portfolio autocorrelation shows the relationship between Biotechnology Portfolio mutual fund current value and its past values and can show if there is a momentum factor associated with investing in Biotechnology Portfolio Biotechnology.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Portfolio financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Portfolio security.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |